Hepatocellular Carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 70 years, male or female; 2. Liver solid tumor, with clinical diagnosis of hepatocellular carcinoma; 3. Normal indocyanine green retention rate at 15min; 4. Adequate liver remnant; 5. Radical hepatectomy according to Chinese Guidelines for diagnosis and treatment of primary liver cancer (2017 Edition); 6. Child-Pugh classification of A to B; 7. No other antitumor therapy and immunotherapy before surgery; 8. No other malignant tumor history; 9. American Society of Anesthesiologists (ASA) grading of I to III 10. Body mass index of between 18 and 35; 11. Able to understand the nature of the study and what will be required of them; 12. Willingness to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women; 2. Active hepatitis; 3. Recurrent HCC; 4. Other situations not suitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| recurrence rate after operation;Quality of Life; | — |
Secondary
| Measure | Time frame |
|---|---|
| Surgical margins;Time to functional recovery;Intraoperative parameters including operation time, pneumoperitoneum time, liver resection time, estimated blood loss, transfusion, as well as number, size and location of the tumor;Postoperative hospital stay;Morbidity and mortality;Hospital costs; | — |
Countries
China
Contacts
The First Affiliated Hospital of Guangxi Medical University